In the United States healthcare system, discussions of value are almost always associated with the equation of quality over cost. However, patients don’t necessarily think that way, explained Yousuf Zafar, MD, MHS, associate professor of medicine and public policy at the Duke Cancer Institute.
In the United States healthcare system, discussions of value are almost always associated with the equation of quality over cost. However, patients don’t necessarily think that way, explained Yousuf Zafar, MD, MHS, associate professor of medicine and public policy at the Duke Cancer Institute.
In his presentation at The American Journal of Managed Care’s 4th Annual Patient-Centered Oncology Care Meeting, Zafar explained that what’s most important to a patient is the cure, or how the care they are going to receive will help them achieve a long, healthy life.
“They value quantity of life, they value quality of life and somewhere in there, maybe if I ask, cost comes up,” he said. “Now it only comes up if I ask; it doesn’t mean that it’s not there as an important part of what they value, but many times, and particularly the first time that patients meet me as an oncologist, they don’t want cost on the list. And the question is: at what point does it become a part of the decision making and when does it become important?”
With this in mind, Zafar said that patients are willing to do anything it takes to receive cancer care. He explained that nearly half of cancer patients are willing to declare bankruptcy, 39% are willing to sell their home, and 73% of individuals are willing to spend less on food and clothing in order to have the means to pay for the care that they need. He explained that studies have also showed that patients with insurance and who also had a cancer diagnosis were more likely to forgo vacations, cut grocery expenses, and tap into their savings and retirement funds in order to meet the financial demands of cancer care.
Much of these economic struggles stem from high out-of-pocket costs for medications, as well as the fact that insurance itself has grown to become very expensive—deductibles have nearly doubled over the last 7 years.
“A recent study found that about 50% of Americans don’t have enough cash on hand to meet the deductibles for these high-deductible plans, so already our patients are entering into the health system unprepared and unable to afford their care, even if they have insurance,” Zafar said.
As a result, it’s not just a person’s bank account that’s being impacted by these financial pressures, but the individual’s well being as well, he added.
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More